1-8 of 8
Andreas Pahl
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Hdp-101, an Anti-BCMA Antibody-Drug Conjugate with a Novel Payload Amanitin in Patients with Relapsed Multiple Myeloma, Initial Findings of the First in Human Study

Jonathan L. Kaufman, Robert Z. Orlowski, Andras Strassz, Andreas Pahl, Thorsten Michaels, Anette Last, Hajnalka Szaboki, Garrit Jentsch, Oliver Schoenborn-Kellenberger, Marc-Steffen Raab
Journal: Blood
Blood (2022) 140 (Supplement 1): 7235–7236.
https://doi.org/10.1182/blood-2022-168848
Published: 2022
Journal Articles

Anti-CD37 α-amanitin–conjugated antibodies as potential therapeutic weapons for Richter syndrome

Tiziana Vaisitti, Nicoletta Vitale, Matilde Micillo, Lorenzo Brandimarte, Andrea Iannello, Mauro Giulio Papotti, Ozren Jaksic, Gianluca Lopez, Arianna Di Napoli, Juan Carlos Cutrin, Christian Orlik, Michael Kulke, Andreas Pahl, Silvia Deaglio
Journal: Blood
Blood (2022) 140 (13): 1565–1569.
https://doi.org/10.1182/blood.2022016211
Published: 2022
Includes: Supplemental data
Journal Articles

Anti-CD37 Alpha-Amanitin Conjugated Antibodies As Therapeutic Weapons for Richter's Syndrome

Tiziana Vaisitti, Nicoletta Vitale, Andrea Iannello, Lorenzo Brandimarte, Matilde Micillo, Mauro Giulio Papotti, Arianna Di Napoli, Christian Orlik, Michael Kulke, Andreas Pahl, Silvia Deaglio
Journal: Blood
Blood (2021) 138 (Supplement 1): 791.
https://doi.org/10.1182/blood-2021-150280
Published: 2021
Journal Articles

A First in Human Study Planned to Evaluate Hdp-101, an Anti-BCMA Amanitin Antibody-Drug Conjugate with a New Payload and a New Mode of Action, in Multiple Myeloma

Andras Strassz, MD, Marc S. Raab, MD, Robert Z. Orlowski, MDPhD, Michael Kulke, PhD, Gudrun Schiedner, PhD, Andreas Pahl, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 34.
https://doi.org/10.1182/blood-2020-142285
Published: 2020
Journal Articles

The Anti-B-Cell Maturation Antigen (BCMA) Antibody-α-Amanitin Conjugate Hdp-101 Induces Immunogenic Cell Death and Immunologic Memory in Models of Multiple Myeloma

Ram Kumar Singh, PhD, Richard J. Jones, PhD, Fazal M. Shirazi, PhD, Jianxuan M. Zou, PhD, Hua Wang, PhD, Hans C. Lee, MD, Elisabet E. Manasanch, MD, Isere Kuiatse, PhD, Andreas Pahl, PhD, Robert Z. Orlowski, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 9–10.
https://doi.org/10.1182/blood-2020-141615
Published: 2020
Journal Articles

HDP101, a Novel B-Cell Maturation Antigen (BCMA)-Targeted Antibody Conjugated to α-Amanitin, Is Active Against Myeloma with Preferential Efficacy Against Pre-Clinical Models of Deletion 17p

Ram Kumar Singh, PhD, Richard J. Jones, PhD, Samuel Hong, PhD, Fazal Shirazi, PhD, Hua Wang, PhD, Isere Kuiatse, PhD, Andreas Pahl, Robert Z. Orlowski, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 593.
https://doi.org/10.1182/blood-2018-99-118412
Published: 2018
Journal Articles

Preclinical Evaluation of Hdp-101, a Novel Anti-BCMA Antibody-Drug Conjugate, in Multiple Myeloma

Jonathan Ko, Christian Breunig, Vianiuhini Figueroa, Nicola Lehners, MD, Anja Baumann, Aniko Pálfi, Christoph Müller, Christian Lutz, Torsten Hechler, Michael Kulke, Carsten Müller-Tidow, Hartmut Goldschmidt, MD, Andreas Pahl, Marc S Raab, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3070.
https://doi.org/10.1182/blood.V130.Suppl_1.3070.3070
Published: 2017
Journal Articles

Gene expression changes in blood after phlebotomy: implications for gene expression profiling

Andreas Pahl, Kay Brune
Journal: Blood
Blood (2002) 100 (3): 1094–1095.
https://doi.org/10.1182/blood-2002-03-0813
Published: 2002